Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0 GBP
−26.83 M GBP
0.00 GBP
58.20 M
About FARON PHARMACEUTICALS OY ORD NPV (DI)
Sector
CEO
Juho Markku Jalkanen
Headquarters
Turku
Website
Founded
2003
ISIN
FI4000153309
FIGI
BBG009YWHTF4
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company, which engages in the development of drugs to treat acute respiratory distress syndrome. Its main drug candidates include Traumakine and Bex. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Veikko Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen, and Markku Tapani Jalkanen in 2003 and is headquartered in Turku, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FARN is 143 GBX — it hasn't changed in the past 24 hours. Watch FARON PHARMACEUTICALS OY ORD NPV (DI) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange FARON PHARMACEUTICALS OY ORD NPV (DI) stocks are traded under the ticker FARN.
FARN stock has fallen by −7.41% compared to the previous week, the month change is a −23.28% fall, over the last year FARON PHARMACEUTICALS OY ORD NPV (DI) has showed a −31.93% decrease.
We've gathered analysts' opinions on FARON PHARMACEUTICALS OY ORD NPV (DI) future price: according to them, FARN price has a max estimate of 231.87 GBX and a min estimate of 99.38 GBX. Watch FARN chart and read a more detailed FARON PHARMACEUTICALS OY ORD NPV (DI) stock forecast: see what analysts think of FARON PHARMACEUTICALS OY ORD NPV (DI) and suggest that you do with its stocks.
FARN reached its all-time high on Feb 28, 2018 with the price of 739 GBX, and its all-time low was 42 GBX and was reached on Jun 19, 2018. View more price dynamics on FARN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FARN stock is 3.57% volatile and has beta coefficient of 2.18. Track FARON PHARMACEUTICALS OY ORD NPV (DI) stock price on the chart and check out the list of the most volatile stocks — is FARON PHARMACEUTICALS OY ORD NPV (DI) there?
Today FARON PHARMACEUTICALS OY ORD NPV (DI) has the market capitalization of 150.45 M, it has decreased by −6.61% over the last week.
Yes, you can track FARON PHARMACEUTICALS OY ORD NPV (DI) financials in yearly and quarterly reports right on TradingView.
FARON PHARMACEUTICALS OY ORD NPV (DI) is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
FARN earnings for the last half-year are −0.14 GBX per share, whereas the estimation was −0.14 GBX, resulting in a −3.09% surprise. The estimated earnings for the next half-year are −0.13 GBX per share. See more details about FARON PHARMACEUTICALS OY ORD NPV (DI) earnings.
FARON PHARMACEUTICALS OY ORD NPV (DI) revenue for the last half-year amounts to 0.00 GBX, despite the estimated figure of 0.00 GBX. In the next half-year revenue is expected to reach 41.61 GBX.
FARN net income for the last half-year is −12.20 M GBP, while the previous report showed −14.93 M GBP of net income which accounts for 18.29% change. Track more FARON PHARMACEUTICALS OY ORD NPV (DI) financial stats to get the full picture.
No, FARN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 34.00 employees. See our rating of the largest employees — is FARON PHARMACEUTICALS OY ORD NPV (DI) on this list?
Like other stocks, FARN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FARON PHARMACEUTICALS OY ORD NPV (DI) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FARON PHARMACEUTICALS OY ORD NPV (DI) technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FARON PHARMACEUTICALS OY ORD NPV (DI) stock shows the strong sell signal. See more of FARON PHARMACEUTICALS OY ORD NPV (DI) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.